Founded in 1965 as a local community pharmacy, Carie Boyd Pharmaceuticals now compounds office-use and patient-specific medications for healthcare providers and patients nationwide. Its FDA-registered 503B outsourcing facility and 503A specialty pharmacy are especially known for implantable hormone pellets, with the company having pioneered an automated pellet-compounding process. The facilities follow cGMP and USP standards while developing customized medications for needs that commercial products may not meet.
FDA-Registered 503B Outsourcing Facility
Registration
Current Good Manufacturing Practices (cGMP), 21 CFR Parts 210 and 211
Compliance program
United States Pharmacopeia (USP) Compliance
Compliance program
FDA503B
Quality certification
USP
Quality certification